Trial intelligence / Profile preview

Luole capsule adjunctive therapy for primary non-small cell lung cancer (qi deficiency and blood stasis pattern)

CTR20132499Phase 2Active

Sponsor
Shandong University of Traditional Chinese Medicine
Start
Jan 2014
Countries
1
01

Overview

A Phase 2 trial of Luole capsule in non-small cell lung cancer (NSCLC), sponsored by Shandong University of Traditional Chinese Medicine. Started Jan 2014; status: active.

02

Drugs

Luole capsule
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on CTR20132499.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132499.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call